CureVac
5 Followers
About
Founded in 2000 as a spin-off from the University of Tϋbingen in Germany, CureVac is a technology leader in the development of drugs that are based on Messenger RNA (mRNA).
- Website
- Headquarters
- Industry
- Social
Team
View all (15)
Franz-Werner Haas
CEO
Bernd Winterhalter
Interim Chief Development Officer
Florian von Der Mülbe
Chief Production Officer and Co-Founder
Igor Splawski
Chief Scientific Officer
Mariola Fotin-Mleczek
Chief Technology Officer
Pierre Kemula
Chief Financial Officer
Antony Blanc
Chief Business Officer and Chief Commercial Officer
Vita Ulrike Gnad - Vogt
Interim Chief Development Officer
Baron Jean Stéphenne
Director
Chris Tanner
Director
Craig A. Tooman
Director
Friedrich von Bohlen und Halbach
Director
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.